|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 31/573 | |
| A61K 31/58 | |||
| A61K 31/7088 | |||
| A61K 38/00 | |||
| A61K 9/00 | |||
| A61K 9/10 | |||
| A61K 9/127 | |||
| A61K 9/19 | |||
| A61P 27/02 |
| (11) | Patento numeris | 2813229 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 14180435.1 |
| Europos patento paraiškos padavimo data | 2010-01-29 | |
| (97) | Europos patento paraiškos paskelbimo data | 2014-12-17 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2018-08-29 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (30) | Numeris | Data | Šalis |
| 538435 | 2009-08-10 | US |
| (72) |
SHIH, Sheue-Fang, TW
CHANG, Po-Chun, TW
TSENG, Yun-Long, TW
GUO, Luke. , S., S.,, US
HONG, Keelung, US
|
| (73) |
TLC Biopharmaceuticals, Inc.,
432 North Canal Street 20, South San Francisco, CA 94080,
US
Taiwan Liposome Co., Ltd., 11F.-1, No. 3, Yuanqu Street Nangang District, Taipei City 115, TW |
| (54) | Ophthalmic drug delivery system containing phospholipid and cholesterol |
| Ophthalmic drug delivery system containing phospholipid and cholesterol |